Immunity to Coccidiosis:
Action of Live Vaccines


Dr. Eng Hong Lee, Vetech Laboratories Inc. and Dr. H.D. Danforth,
USDA Agricultural Research Service


Introduction

Live oocysts vaccines against coccidiosis in chickens have been used by the poultry industry since the introduction of CoccivacTM in 1965 and ImmucoxTM 20 years later. Over 3 billion doses of the 4 brands of vaccines have been sold for chickens. Two of these vaccines (CoccivacTM and ImmucoxTM) contain oocyst strains originally isolated from the field while the other two vaccines (ParacoxTM and LivacoxTM) use some or all attenuated or precocious strains of coccidia. All of these vaccines induce protective immunity to coccidial infection.

The vaccines have been successful for breeder flocks, and over the last few years there is a steady increase in use for commercial broilers and roasters. Recent reviews on the immune response of chickens to coccidial infection and immunization allows for a more complete discussion on how live oocyst vaccines function.

Coccidial life cycle

There are 7 different species of coccidia (genus Eimeria) commonly found in the intestinal tract of the chicken and each infects specific areas of the gut. Except for the infective oocyst stage, which is shed in feces onto the litter, the remainder of the coccidial life cycle takes place in the intestinal tract. Sporulated oocysts are ingested by the bird. These release the invasive sporozoite stages that penetrate the gut cells to initiate development of asexual intracellular schizonts. The schizonts produce large numbers of a second invasive stage, termed the merozoite, which penetrates other gut cells to produce a further generation of schizonts.

The number of asexual generations varies from 2 to 4 depending on the species of coccidia. Asexual multiplication results in an exponential increase in parasite numbers. Ultimately we see the intracellular macro and micro- gametocyte stages of the life cycle give rise to macro and microgametes, which fuse to form a zygote. This stage develops into an immature oocyst, which is shed onto the litter. The Eimeria lifecycle is extremely efficient with the potential to produce 300,000 oocysts following infection of the susceptible chicken with a single sporulated oocyst.

 

 
Life Cycle of E. tenella

 


 

Role of immune response

The complex life cycle stimulates a number of immunological responses, which will vary in anticoccidial effect. The response comprises both nonspecific and specific responses by the immune system. These have evolved in the intestine to respond against invasive viral, bacterial and parasitic pathogens. Extra and intracellular developmental stages of coccidia will stimulate both humoral and cellular immuno-logical responses with an initial or primary infection in addition to subsequent secondary reinfection. The immune response is specific to each of the 7 chicken coccidial species.

Immunovariability between  strains of the same species of coccidia occurs, which may result in a corresponding lack of cross protection. It is possible to protect flocks against one species or strain of coccidia.Complete or partial susceptibility may persist with infection by another species or variant strain of the same species of Eimeria. Humoral responses in the form of serum antibody and local   intestinal mucosal antibody produced by mucin and B lymphocytes are a direct result of the interaction between macrophages and other antigen-presenting cells and the invading sporozoite and merzoite stages of the Eimeria lifecycle. This response, derived from complex interactions between macrophages, lympho-cytes, dendritic and epithelial cells, represents the first line of defense to any invasive organism in the intestine. Although highly effective against bacterial colonization and viral infection, the humoral response to coccidial infection is limited in scope. It may play some role with the early phase of parasite infection or the later sexual stages of development. Cell mediated immune response that has the major role in inhibition coccidial infection and development of intracellular parasites. Cell mediated immune response to coccidial infection represents a complex interaction of the parasite with gut associated immune function.

A thorough understanding of this process requires the identification of various T lymphocyte populations, characterization of the function of macrophage,  dendritic and natural kill (NK) cells, and elucidation of cytokine and lymphokine immune response regulation. Investigations in these areas are still incomplete for avian coccidia, but comparisons between studies on coccidiosis in chickens and the results from other parasitic infection models in mice now provide a better understanding on the complicated process of anticoccidial cell mediated immunity (CMI).

 



Immune Responses to Coccidiosis


 

Antigen-specific and non-specific activation of  T lymphocytes, NK cells and macrophages are necessary components of this CMI process. There is strong evidence the intraepithelial T lymphocytes with surface pheno-types positive for CD8+, mediate host immunity to coccidial parasites. Sporozoites occur within the CD8+ lymphocytes during primary coccidial infection, which indicates that these cells may be involved in transport of sporozoites within the gut.  Increased numbers of the T cells sometimes appear as early as 8 days post infection in the epithelium of the gut following secondary coccidial infections. They are also seen in direct contact with infected epithelial gut cells. This suggests that the CD8+cells are cytotoxic in nature and may destroy the infected host cells.

Further confirmation of the importance of CD8+ T cells in cellular response to coccidial infection is seen in studies that deplete the CD8+ cells by treatment of anti-CD8+ mono-clonal antibody. More oocysts are produced during primary infection in birds subjected to anti-CD8+ treatment than were measured in untreated and infected controls. This treatment before secondary infections completely abolished resistance to this challenge infection.

The NK cells seem to play an important role in local early defense of coccidial infection, while macrophages may be more important in phagocytosis of the sporozoite stages. Both types of cells are known secretors of cytokines during and after coccidial infection. Observations of chicken intestinal intra-epithelial lymphocytes (IIEL) have shown that the associated NK cells mediate spontaneous cytotoxicity. These cells are found in the greatest numbers in the early stages of coccidial infection, suggesting a possible role in control of parasite proliferation. In addition, levels of NK cell activity in the intraepithelium, increased in infected animals and coincided with parasite elimination. This indicates that the IEL NK cells may be involved in blocking invasion of the gut by sporozoites. Growing evidence on cytokines and lymphokines produced during coccidial infection and immunization suggest that these are the important molecules in controlling host CMI responses. Tumor necrosis factor-a (TNF-a) is secreted by NK cells and macrophages and has been shown to exert a protective effect in coccidial infections. Interferon-gamma (JFN-y) is believed to play a critical role in protection of chickens against coccidia infection as evidenced by increased bird weight gains, decreased oocyst production and inhibition of intracellular parasite development of IFN-y tented birds. Exactly how WN-y regulates anticoccidial activity is not known, but the fact is that this cytokine activates macrophages, NK cells and cytotoxic T lymphocytes ruakes it an important participant in CMI anticoccidial protection.



Live oocyst vaccines

Live oocysts vaccines direct the immunological response of the chicken by stimulating the immune system towards protection against specific coccidial infection. Antigen presenting cells (macrophages and dendritic cells) combined with NK cells, T-cell-secreted cytokines (IFN-y and TNF) and CD8+ cells are needed to produce response against coccidial reinfection.

Based on the known role of the immune response of the chicken to coccidiosis, it is likely that Th- 1 rather than Th-2 cell biased response occurs. This requires that low (and not high) levels of a primary parasite infection should be given to flocks to initiate the cascade of events to produce Th-l cells. The secretion of IFN-y, TNF and possibly other cytokines would then act through host receptors to limit coccidial development.  Although a direct role of CD8+ cells in CMI response for resistance to coccidiosis is still unproven, the presence of significantly higher numbers of CD8+ IL near parasitized cells in immunized birds further suggests that soluble cytokines combined with cytotoxic T cells are involved in the protective CMI response to coccidiosis. Correspondingly, higher levels of parasite invasions such as those observed with drug resistant infections in laboratory and field studies appear to induce a Th-2 cell response (Figure 2), which would not establish protection in the birds. Invasions by large numbers of coccidial parasites would mimic bacterial or viral infection and thereby drive the gut-associated lymphoid tissue immune system toward a B cell type response. This may in part explain why treatment for coccidiosis after heavy infection with drug-resistant field strains of Eimeria must be repeated more than once to control infection.

The recent findings that IL-4, IL5 and IL-6 deficient birds actually produce lower numbers of parasite stages than the cytokine-intact infected controls lend further credence to inhibition of immune coccidial protection by the Th-2 biased response. It is therefore imperative to ensure levels of primary oocyst exposure to insure that the correct immune response is elicited. Immunization with live vaccines is therefore completely different from field infections involving high levels of parasite infection. This makes a live coccidiosis vaccine more desirable because the birds are programmed to produce the protective response before they are exposed to field challenge.

Published in Zootechnica International, June 1999



Disclaimer
Copyright © 2007, Vetech Laboratories Inc.